标题
Long-Acting Antiretrovirals: Where Are We now?
作者
关键词
Long-acting antiretrovirals, HIV treatment, HIV prevention, Pre-exposure prophylaxis
出版物
Current HIV/AIDS Reports
Volume 14, Issue 2, Pages 63-71
出版商
Springer Nature
发表日期
2017-03-16
DOI
10.1007/s11904-017-0353-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges
- (2016) Martina Kovarova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
- (2016) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment
- (2016) Ian McGowan et al. Lancet HIV
- Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa
- (2016) Annalene Nel et al. PLoS One
- Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis
- (2015) Manjula Gunawardana et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations
- (2015) Pavan Puligujja et al. BIOMATERIALS
- The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy
- (2015) Eric L. Ross et al. CLINICAL INFECTIOUS DISEASES
- Safety, tolerability and pharmacokinetics of rilpivirine following administration of a long-acting formulation in healthy volunteers
- (2015) R Verloes et al. HIV MEDICINE
- Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy
- (2015) Shilpa Viswanathan et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA)
- (2015) Kerri J. Penrose et al. JOURNAL OF INFECTIOUS DISEASES
- Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
- (2015) Rochelle P. Walensky et al. JOURNAL OF INFECTIOUS DISEASES
- Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial
- (2015) David A Margolis et al. LANCET INFECTIOUS DISEASES
- The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge
- (2015) J. Radzio et al. Science Translational Medicine
- Formulation and pharmacology of long-acting rilpivirine
- (2015) Peter E. Williams et al. Current Opinion in HIV and AIDS
- A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women
- (2014) Annalene Nel et al. AIDS
- Pharmacokinetics of Injectable, Long-Acting Nevirapine for HIV Prophylaxis in Breastfeeding Infants
- (2014) John M. Cortez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
- (2014) K. Rivet Amico et al. CLINICAL INFECTIOUS DISEASES
- Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials
- (2014) Jean B. Nachega et al. CLINICAL INFECTIOUS DISEASES
- A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis
- (2014) A G A Jackson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- GSK1265744 Pharmacokinetics in Plasma and Tissue After Single-Dose Long-Acting Injectable Administration in Healthy Subjects
- (2014) William Spreen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Enhanced neonatal Fc receptor function improves protection against primate SHIV infection
- (2014) Sung-Youl Ko et al. NATURE
- High Interest in a Long-Acting Injectable Formulation of Pre-Exposure Prophylaxis for HIV in Young Men Who Have Sex with Men in NYC: A P18 Cohort Substudy
- (2014) Kathrine Meyers et al. PLoS One
- Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus
- (2014) C. D. Andrews et al. SCIENCE
- Cause-specific mortality among HIV-infected individuals, by CD4+ cell count at HAART initiation, compared with HIV-uninfected individuals
- (2013) Nikolas Wada et al. AIDS
- Cause-Specific Life Expectancies After 35 Years of Age for Human Immunodeficiency Syndrome-Infected and Human Immunodeficiency Syndrome-Negative Individuals Followed Simultaneously in Long-term Cohort Studies, 1984–2008
- (2013) Nikolas Wada et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy
- (2013) Nagsen Gautam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744
- (2013) Susan L. Ford et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor
- (2013) W. Spreen et al. HIV CLINICAL TRIALS
- Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients
- (2013) Jennifer Williams et al. Nanomedicine
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada
- (2013) Hasina Samji et al. PLoS One
- Long-Term Efficacy, Safety, and Tolerability of Rilpivirine (RPV, TMC278) in HIV Type 1-Infected Antiretroviral-Naive Patients: Week 192 Results from a Phase IIb Randomized Trial
- (2011) Aimee Wilkin et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular delivery
- (2011) Rainer H. Müller et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Depression and HIV/AIDS Treatment Nonadherence: A Review and Meta-analysis
- (2011) Jeffrey S Gonzalez et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
- (2010) Frederick L Altice et al. LANCET
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
- (2010) T. Zhou et al. SCIENCE
- TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1
- (2009) H. Azijn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search